Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2014
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014847/
http://dx.doi.org/10.1182/blood-2014-04-567313
_version_ 1782315247345860608
collection PubMed
description
format Online
Article
Text
id pubmed-4014847
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-40148472014-06-12 Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934. Blood Errata American Society of Hematology 2014-05-08 /pmc/articles/PMC4014847/ http://dx.doi.org/10.1182/blood-2014-04-567313 Text en © 2014 by The American Society of Hematology
spellingShingle Errata
Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title_full Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title_fullStr Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title_full_unstemmed Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title_short Oaks JJ, Santhanam R, Walker CJ, et al. Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood. 2013;122(11):1923-1934.
title_sort oaks jj, santhanam r, walker cj, et al. antagonistic activities of the immunomodulator and pp2a-activating drug fty720 (fingolimod, gilenya) in jak2-driven hematologic malignancies. blood. 2013;122(11):1923-1934.
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014847/
http://dx.doi.org/10.1182/blood-2014-04-567313

Ejemplares similares